Zinc promotes functional recovery after spinal cord injury by activating Nrf2/HO-1 defense pathway and inhibiting inflammation of NLRP3 in nerve cells

Life Sci. 2020 Mar 15:245:117351. doi: 10.1016/j.lfs.2020.117351. Epub 2020 Jan 22.

Abstract

Aims: To study the specific therapeutic effect of zinc on spinal cord injury (SCI) and its specific protective mechanism.

Main methods: The effects of zinc ions on neuronal cells were examined in a mouse SCI model and in vitro. In vivo, neurological function was assessed by Basso Mouse Scaleat (BMS) at 1, 3, 5, 7, 10, 14, 21, and 28 days after spinal cord injury. The number of neurons and histomorphology were observed by nissl staining and hematoxylin-eosin staining (HE). The chromatin and mitochondrial structure of neurons were detected by transmission electron microscopy (TEM). The expression of nuclear factor erythroid 2 related factor 2 (Nrf2)-related antioxidant protein and NLRP3 inflammation-related protein were detected in vivo and in vitro by western blot (WB) and immunofluorescence (IF), respectively.

Key findings: Zinc treatment promoted motor function recovery on days 3, 5, 7, 14, 21 and 28 after SCI. In addition, zinc reduces the mitochondrial void rate in spinal neuronal cells and promotes neuronal recovery. At the same time, zinc reduced the levels of reactive oxygen species (ROS) and malondialdehyde in spinal cord tissue after SCI, while increasing superoxide dismutase activity and glutathione peroxidase production. Zinc treatment resulted in up-regulation of Nrf2/Ho-1 levels and down-regulation of nlrp3 inflammation-associated protein expression in vitro and in vivo.

Significance: Zinc has a protective effect on spinal cord injury by inhibiting oxidative damage and nlrp3 inflammation. Potential mechanisms may include activation of the Nrf 2/Ho-1 pathway to inhibit nlrp3 inflammation following spinal cord injury. Zinc has the potential to treat SCI.

Keywords: NF-E2-related factor (Nrf2); NLRP3 inflflammasome; Oxidative stress; Spinal cord injury; Zinc.

MeSH terms

  • Animals
  • Blotting, Western
  • Disease Models, Animal
  • Female
  • Fluorescent Antibody Technique
  • Heme Oxygenase-1 / metabolism*
  • In Situ Nick-End Labeling
  • Male
  • Membrane Proteins / metabolism*
  • Mice
  • Mice, Inbred C57BL
  • Microscopy, Electron, Transmission
  • NF-E2-Related Factor 2 / metabolism*
  • NLR Family, Pyrin Domain-Containing 3 Protein / metabolism*
  • Neurons / drug effects*
  • Neurons / metabolism
  • Neuroprotective Agents / pharmacology
  • Neuroprotective Agents / therapeutic use*
  • Signal Transduction / drug effects*
  • Spinal Cord / cytology
  • Spinal Cord / drug effects
  • Spinal Cord / metabolism
  • Spinal Cord / pathology
  • Spinal Cord Injuries / drug therapy*
  • Spinal Cord Injuries / metabolism
  • Spinal Cord Injuries / pathology
  • Zinc / pharmacology
  • Zinc / therapeutic use*

Substances

  • Membrane Proteins
  • NF-E2-Related Factor 2
  • NLR Family, Pyrin Domain-Containing 3 Protein
  • Neuroprotective Agents
  • Nfe2l2 protein, mouse
  • Nlrp3 protein, mouse
  • Heme Oxygenase-1
  • Hmox1 protein, mouse
  • Zinc